Skip To Main Content
Arnulf Stenzl on Muck Rack

Arnulf Stenzl

Tübingen
As seen in: Color Research & Application, Nature, European Urology, UroToday, Urology News, BJU International Journal
Director of the Department of Urology, University Hospital Tuebingen | Chairman of the EAU Scientific Congress Office
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arnulf

Contact Arnulf, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ASCO 2026: Efficacy and Safety of Enzalutamide in Patients with mHSPC and Cardiometabolic Comorbidities And/or Related Concomitant Medications: ARCHES Post Hoc

|
By Julian Chavarriaga, Arnulf Stenzl
| UroToday Verified
(UroToday.com) The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting held in Chicago, IL, was host to Prostate, Testicular, and Penile Cancer – Posters Session. Dr. Arnulf Stenzl presented Abstract 5092: Efficacy and safety of enzalutamide in patients with mHSPC and cardiometabolic comorbidities and/or related concomitant medications: ARCHES post hoc.
Open in Who Shared Issue with article?

Active surveillance in low-grade NMIBC — results of an international two-round modified Delphi consensus

|
By Roberto Contieri, Paolo Gontero, Rodolfo Hurle, Luca Afferi, Simone Albisinni, Marek Babjuk, Alison Birtle, Peter Black, Maurizio Brausi, Otakar Capoun, Albert Carrion, James Catto, Ananya Choudhury, Alessia Cimadamore, Eva M. Compérat, Siamak Daneshmand, David D’Andrea, Francesco Del Giudice, Patrick J. Hensley, Wojciech W. Krajewski, Ekaterina Laukhtina, Roger Li, Fredrik Liedberg, Yair Lotan, Gautier Marcq, Paramananthan Mariappan, Andrea Mari Verified, Alberto Martini, Richard P. Meijer, Maria Carmen Mir, Keiichiro Mori, Marco Moschini, Hugh Mostafid, Joan Palou, Valeria Panebianco, Sisto Perdonà, Sima Porten, Sarah P. Psutka, Michael Rink, Morgan Rouprêt, Thomas Seisen, Mark Soloway, Viktor Soukup, Gary D. Steinberg, Arnulf Stenzl, Karl H. Tully, Toine Van der Heijden, Toine van der Heijden, Bas W. G. van Rhijn, Alfred Witjes, Evanguelos Xylinas, Ashish M. Kamat, Benjamin Pradere, Laura Mertens, Max Bruins, Alexandra Masson Lecomte, Micheal O’Donnell, Jeremy YC Teoh
| Nature Verified
Abstract Standard management for recurrent low-grade non-muscle-invasive bladder cancer (LG-NMIBC) often involves a substantial treatment burden, which is not justified by the relatively indolent course of the disease, prompting a need for de-intensification strategies. Active surveillance (AS) is an alternative approach aimed at reducing overtreatment in selected patients.
Open in Who Shared Issue with article?

ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients

|
By Andrew Armstrong, Daniel P. Petrylak, Neal Shore, START Carolinas, Russell Szmulewitz, Jeffrey M. Holzbeierlein, Arnauld Villers, Antonio Alcaraz, Boris Alekseev, Taro Iguchi, Francisco Gomez-Veiga, Ruishan Wu, Yiyun Tang, Arnulf Stenzl, Ruslan Croitoru, Matko Kalac
| European Urology Verified
Original ArticleArticles in PressOpen access aDuke Cancer Institute Center for Prostate & Urologic Cancers, Duke University, Durham, NC, USA bYale School of Medicine, New Haven, CT, USA cSTART Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC, USA dDepartment of Medicine, University of Chicago, Chicago, IL, USA eUniversity of Kansas Medical Center, Kansas City, KS, USA fDepartment of Urology, University of Lille, Lille, France gDepartment of Urology, Hospital Clínic de Barcelona,...
Open in Who Shared Issue with article?
See all 21 licensed articles (22 Total)